NASDAQ · Analyst Forecast

Roivant Sciences Ltd. (ROIV) Stock Forecast & Price Target

$39.35 NASDAQ: ROIV Market Cap $28.51B

Price as of Nov 16, 2026 (intraday, delayed) · Analyst estimates retrieved Nov 13, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Roivant Sciences Ltd. (ROIV), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Roivant Sciences Ltd., analysts forecast revenue rising from GBP 9.09M in 2026 to GBP 5.61B in 2031; the average estimate for 2031 earnings per share is GBP 2.86; with published estimates ranging from GBP 1.05 to GBP 4.66; 9 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$39.35
Consensus targetThe average of the price targets analysts have published.$47.71
Median targetThe middle target, less affected by a single outlier.$47.00
Highest targetThe most optimistic published target.$55.00
Lowest targetThe most pessimistic published target.$41.00
Difference from priceHow far the consensus target sits from today’s price.+21.2%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (GBP)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2026GBP 6.63MGBP 9.09MGBP 11.56M8
2027GBP 93.62MGBP 148.05MGBP 217.21M3
2028GBP 332.74MGBP 618.80MGBP 860.20M9
2029GBP 998.87MGBP 1.60BGBP 2.14B6
2030GBP 1.68BGBP 3.27BGBP 4.86B3
2031GBP 2.89BGBP 5.61BGBP 8.34B2

Earnings per share forecast (GBP)

YearLowAverageHighAnalysts
2026−GBP 1.83−GBP 1.12−GBP 0.418
2027−GBP 1.92−GBP 1.18−GBP 0.433
2028−GBP 1.86−GBP 1.14−GBP 0.429
2029−GBP 5.21−GBP 0.54GBP 6.116
2030GBP 0.37GBP 1.00GBP 1.643
2031GBP 1.05GBP 2.86GBP 4.662

Roivant Sciences Ltd. (ROIV) forecast — frequently asked questions

What is the analyst price target for Roivant Sciences Ltd.?

Analysts covering Roivant Sciences Ltd. (ROIV) have a consensus price target of $47.71, 21.2% above the current price of $39.35. Published targets range from $41.00 to $55.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Roivant Sciences Ltd.'s earnings?

The average analyst estimate for Roivant Sciences Ltd. (ROIV) earnings per share in 2031 is 2.86, with individual estimates between 1.05 and 4.66.

How much revenue is Roivant Sciences Ltd. expected to make?

Analysts forecast Roivant Sciences Ltd. (ROIV) revenue of GBP 5.61B in 2031, based on 2 published estimates.

How many analysts cover ROIV?

9 analysts contribute estimates for Roivant Sciences Ltd. (ROIV). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastEXEL forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.